Causaly

London, UK · ≈100 employees · causaly.com

Causaly is a London-based artificial intelligence company founded in 2018, specializing in a biomedical research platform that accelerates drug discovery and life sciences research. The company was established by Yiannis Kiachopoulos and Artur Saudabayev, who met at Singularity University. Causaly's mission is to enhance human discovery by using AI to quickly find, visualize, and interpret biomedical knowledge, significantly reducing research time. The core offering is an AI-driven biomedical research platform that allows scientists to explore complex causal relationships across extensive data sources, including millions of scientific publications. Key features include deep search capabilities, generative AI copilots for automating research workflows, and a sophisticated knowledge graph containing over 500 million facts. Causaly serves the pharmaceutical and life sciences sectors, including major pharmaceutical companies and research institutions, helping them improve research productivity and accelerate insights. The company has raised over $93 million in funding to support its growth and development.